| Date | Guest speakers | Title lecture |
| 14 June 2010 | Martijn Gloerich (Dept. of Physiological Chemistry, Centre for Biomedical Genetics and Cancer Genomics Centre, Utrecht) | ‘Direct spatial control of Epac1 by cyclic AMP’ |
| 21 June 2010 | Nicole P. Juffermans (Dept. of Intensive Care Medicine, AMC) | ‘TRALI in the critically ill’ |
| 28 June 2010 | Janine van Gils (Department of Medicine, The Leon H. Charney Division of Cardiology, New York University School of Medicine, USA) | ‘Netrin-1: A multifunctional guidance cue that promotes atherosclerosis‘ |
| Landsteiner Lectures & Masterclasses |
 | Lecture | Masterclass |
| 25 November 2010: prof. dr. Olivier Pertz (Dept. of Cell Migration and Neuritogenesis, University of Basel) |  | ‘Real-time imaging in cell biology’ |
| 30 September 2010: Masterclass Prof. Dietmar Vestweber (Max Planck Institute for Molecular Biomedicine) |  | 'Dynamics of cell-cell junctions' |
| 22 June 2009: Marloes Tijssen (University of Cambridge, Department of Haematology, Cambridge Institute for Medical Research UK) | ‘Comparison of the gene regulatory programs of blood stem cells and megakaryocytes’ |  |
| 14 March 2007: Prof. Keith Burridge (University of North Carolina, USA) | ‘The role of small GTPases in cellular functions’ |  |
| 28 August 2006: Prof. dr. Dennis Burton (The Scripps Research Institute, La Jolla, USA) | 'Neutralizing antibodies and HIV vaccine design' | 'Neutralizing Antibodies' |
| 10 March 2006: Dr. Mark Ginsberg (Univerity of California at San Diego). | ‘Integrin Signaling in Inflammation and Cancer’ | ‘Integrin Activation and Signalling in Cell Adhesion’ |
| 27 October 2003: Robin W. Carrell MD PhD (Department of Hematologie, University of Cambridge) | 'How serpins change their fold and what can we do about it?' |  |
| 29 September 2003: Prof. Laurence A. Boxer MD PhD (University of Michigan Health System, Ann Arbor, MI, USA) | The role of ceramide and its metabolites in regulating phagocytosis |  |
| 26 May 2003: Prof. Clark Anderson PhD | 'IgG and albumin transport by the MHC-like Fc receptor, FcRn' |  |
| 20 January 2003: Prof. dr. J.C. Jensenius (University of Aarhus, Dept. of Medical Microbiology and Immunology, Denmark) | 'The MBL pathway of complement. An update' |  |